YUPELRI vs ZORYVE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated June 7, 2026·How we rate

Possible drug interaction. YUPELRI and ZORYVE are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	YUPELRI	ZORYVE
Rating	New	New
Pharmacy pays	—	~$10.09 /30
Type	RX	RX
Active ingredient	REVEFENACIN	ROFLUMILAST
Manufacturer	Mylan Ireland Ltd	Arcutis
Dosage forms	Solution	Spray/Inhaler, Topical
Drug class	—	Phosphodiesterase 4 Inhibitor
Boxed warning	None	None
Treats	Chronic Obstructive Pulmonary Disease	Chronic Obstructive Pulmonary Disease

yupelri zoryve

Rating

New

Pharmacy pays

—

~$10.09 /30

Type

Active ingredient

REVEFENACIN

ROFLUMILAST

Manufacturer

Mylan Ireland Ltd

Arcutis

Dosage forms

Solution

Spray/Inhaler, Topical

Drug class

—

Phosphodiesterase 4 Inhibitor

Boxed warning

None

Treats

Chronic Obstructive Pulmonary Disease

Frequently asked questions

What is the difference between Yupelri and Zoryve?

Yupelri contains Revefenacin, while Zoryve contains Roflumilast — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.